학술논문

Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs
Document Type
Article
Source
In JACC: Heart Failure August 2023 11(8) Part 1:933-942
Subject
outcomes-and-quality
Language
ISSN
2213-1779